(1)
Farahani, P.; Khan, S.; Oatway, M.; Dziarmaga, A. EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING. J Popl Ther Clin Pharmacol 2018, 22 (3).